Cargando…

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab

Detalles Bibliográficos
Autor principal: Park, Jung-Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671030/
https://www.ncbi.nlm.nih.gov/pubmed/34905681
http://dx.doi.org/10.11005/jbm.2021.28.4.339
_version_ 1784615083173740544
author Park, Jung-Wee
author_facet Park, Jung-Wee
author_sort Park, Jung-Wee
collection PubMed
description
format Online
Article
Text
id pubmed-8671030
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society for Bone and Mineral Research
record_format MEDLINE/PubMed
spelling pubmed-86710302021-12-23 Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab Park, Jung-Wee J Bone Metab Letter to the Editor The Korean Society for Bone and Mineral Research 2021-11 2021-11-30 /pmc/articles/PMC8671030/ /pubmed/34905681 http://dx.doi.org/10.11005/jbm.2021.28.4.339 Text en Copyright © 2021 The Korean Society for Bone and Mineral Research https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Park, Jung-Wee
Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title_full Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title_fullStr Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title_full_unstemmed Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title_short Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
title_sort insufficient mitigation of bone loss by zoledronic acid after treatment with denosumab
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671030/
https://www.ncbi.nlm.nih.gov/pubmed/34905681
http://dx.doi.org/10.11005/jbm.2021.28.4.339
work_keys_str_mv AT parkjungwee insufficientmitigationofbonelossbyzoledronicacidaftertreatmentwithdenosumab